{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:59:28Z","timestamp":1780765168592,"version":"3.54.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"DOI":"10.7759\/cureus.110361","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:05:38Z","timestamp":1780761938000},"source":"Crossref","is-referenced-by-count":0,"title":["Syncytial Variant of Nodular Sclerosis Classical Hodgkin\u2019s Lymphoma With Hemophagocytic Lymphohistiocytosis: A Rare and Under-Characterized Entity"],"prefix":"10.7759","author":[{"given":"Zoya","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Yaseen O P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shramana","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang J","year":"2022","unstructured":"Huang J, Pang WS, Lok V, et al.. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. J Hematol Oncol. 2022, 15:57. 10.1186\/s13045-022-01281-9","journal-title":"J Hematol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2021.05.008","article-title":"Syncytial variant of nodular sclerosis Hodgkin lymphoma: an under-emphasized variant","volume":"117","author":"Wang W","year":"2021","unstructured":"Wang W, Zhang Q, Medeiros LJ. Syncytial variant of nodular sclerosis Hodgkin lymphoma: an under-emphasized variant. Hum Pathol. 2021, 117:115-25. 10.1016\/j.humpath.2021.05.008","journal-title":"Hum Pathol"},{"key":"ref4","article-title":"The pathology and nomenclature of Hodgkin's disease","volume":"26","author":"Lukes RJ","year":"1966","unstructured":"Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966, 26:1063-83.","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716676256","article-title":"Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma","volume":"8","author":"Sethi T","year":"2017","unstructured":"Sethi T, Nguyen V, Li S, Morgan D, Greer J, Reddy N. Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma. Ther Adv Hematol. 2017, 8:13-20. 10.1177\/2040620716676256","journal-title":"Ther Adv Hematol"},{"key":"ref6","article-title":"Lymphohistiocytosis","author":"Konkol S","year":"2025","unstructured":"Konkol S, Killeen RB, Rai M. Lymphohistiocytosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00366-5","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis","volume":"9","author":"Setiadi A","year":"2022","unstructured":"Setiadi A, Lorenz AZ, Lee CY, Jordan MB, Chen LY. Malignancy-associated hemophagocytic lymphohistiocytosis. Lancet Haematol. 2022, 9:E217-27. 10.1016\/S2352-3026(21)00366-5","journal-title":"Lancet Haematol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the Histiocyte Society","volume":"28","author":"Henter JI","year":"1997","unstructured":"Henter JI, Aric\u00f2 M, Egeler RM, et al.. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the Histiocyte Society. Med Pediatr Oncol. 1997, 28:342-7.","journal-title":"Med Pediatr Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska M","year":"2017","unstructured":"Pilichowska M, Pittaluga S, Ferry JA, et al.. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv. 2017, 1:2600-9. 10.1182\/bloodadvances.2017009472","journal-title":"Blood Adv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens AM","year":"2015","unstructured":"Evens AM, Kanakry JA, Sehn LH, et al.. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. Am J Hematol. 2015, 90:778-83. 10.1002\/ajh.24082","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.152256","article-title":"Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association","volume":"102","author":"Sarkozy C","year":"2017","unstructured":"Sarkozy C, Molina T, Ghesqui\u00e8res H, et al.. Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica. 2017, 102:150-9. 10.3324\/haematol.2016.152256","journal-title":"Haematologica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488827-syncytial-variant-of-nodular-sclerosis-classical-hodgkins-lymphoma-with-hemophagocytic-lymphohistiocytosis-a-rare-and-under-characterized-entity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:05:40Z","timestamp":1780761940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488827-syncytial-variant-of-nodular-sclerosis-classical-hodgkins-lymphoma-with-hemophagocytic-lymphohistiocytosis-a-rare-and-under-characterized-entity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.110361","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}